货号:A414150 同义名: 右兰索拉唑 / Dexlansoprazole;T-168390
(R)-Lansoprazole, the dextrorotatory enantiomer of lansoprazole, can irreversibly inactivate the H+/K+-stimulated ATPase pump.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Proton Pump ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zinc pyrithione | ✔ | 98+% | |||||||||||||||||
PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
98% | |||||||||||||||||
Lansoprazole | ✔ | 98% | |||||||||||||||||
Esomeprazole Magnesium | ✔ | 98%+ | |||||||||||||||||
Rabeprazole | ✔ | 99%+ | |||||||||||||||||
Ilaprazole | ✔ | TOPK | 97% | ||||||||||||||||
Bafilomycin A1 |
++++
H+-ATPase, IC50: 0.44 nM |
95% | |||||||||||||||||
Pantoprazole sodium | ✔ | 98% | |||||||||||||||||
(R)-Lansoprazole | ✔ | 98% | |||||||||||||||||
Tenatoprazole | ✔ | 99%+ | |||||||||||||||||
Omeprazole | ✔ | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | (R)-Lansoprazole is the R enantiomer of Lansoprazole. Lansoprazole (AG 1749) is an orally active proton pump inhibitor that suppresses gastric acid production. Additionally, Lansoprazole (AG 1749) is a potent brain-penetrating inhibitor of neutral sphingomyelinase (N-SMase), which also acts as an exosome inhibitor[1][2]. |
体外研究 | The plasma concentrations of (R)-lansoprazole are notably elevated across all three CYP2C19 genotype groups compared to the corresponding (S)-enantiomer. In terms of AUC0-∞, Cmax, and elimination half-life, (R)-lansoprazole exhibits significantly higher values and longer durations compared to the (S)-enantiomer across all genotype groups[3]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00274339 | Laryngopharyngeal Reflux | Not Applicable | Unknown | June 2008 | United States, Kentucky ... 展开 >> Commonwealth Ear, Nose & Throat Recruiting Louisville, Kentucky, United States, 40207 Contact: Marti Gardner, MSN 502-893-0159 ext 1185 mgardner@commonwealthent.com Principal Investigator: Kenneth M Hodge, MD Sub-Investigator: John R Morris, MD Sub-Investigator: Donald V Welsh, MD Sub-Investigator: Gorden T McMurry, MD Sub-Investigator: Andrew R Gould, MD Sub-Investigator: Keith D Forwith, PhD, MD Sub-Investigator: Steven D Shotts, MD Sub-Investigator: Tamalynn O'Daniel, MSN, ARNP Sub-Investigator: Jolene H Boswell, PA-C Sub-Investigator: Mary S McLaughlin, PA-C Sub-Investigator: Martha L Gardner, MSN, ARNP Sub-Investigator: Brian Walker, PA-C 收起 << |
NCT02297126 | Adverse Drug Reaction | Not Applicable | Completed | - | United States, Indiana ... 展开 >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 收起 << |
NCT00237679 | Voice Disorders ... 展开 >> Gastroesophageal Reflux 收起 << | Not Applicable | Terminated(Terminated due to f... 展开 >>unding loss.) 收起 << | - | United States, Wisconsin ... 展开 >> University of Wisconsin Madison, Wisconsin, United States, 53792 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.71mL 0.54mL 0.27mL |
13.54mL 2.71mL 1.35mL |
27.07mL 5.41mL 2.71mL |
CAS号 | 138530-94-6 |
分子式 | C16H14F3N3O2S |
分子量 | 369.361 |
别名 | 右兰索拉唑 ;Dexlansoprazole;T-168390;TAK-390;(+)-Lansoprazole |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(284.27 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |